Connor, Clark & Lunn Investment Management Ltd. Vanda Pharmaceuticals Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 819,382 shares of VNDA stock, worth $3.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
819,382
Previous 780,933
4.92%
Holding current value
$3.9 Million
Previous $3.66 Million
7.15%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
43.7MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$38.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$18.3 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$16.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11.2 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $269M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...